PBS Documentary Features Pioneering Generation of Women Doctors

Becoming a doctor during the 19th century was difficult for anyone to accomplish. For women, the feat was nearly impossible. Now, that rare accomplishment will be featured in a new documentary from Florida State University College of Motion Picture Arts filmmaker in...

Abstracts Invited for ASTM International Virtual Workshop on Fast-Tracking PPE Standards Development

Abstracts for presentation are invited for the ASTM International virtual workshop on Fast-Tracking Standards Development to Address Personal Protective Equipment (PPE) Shortages Due to the COVID-19 Pandemic, Sept. 9-10, 2020. ASTM International’s committees on...

340 Organizations Send Letter to Congress Urging Action on Telehealth

On Tuesday 340 organizations signed a letter urging Congressional leaders to make telehealth flexibilities created during the COVID-19 pandemic permanent. Those signing this multi-stakeholder letter include national and regional organizations representing a full range...

AAAHC Enhances Standards in New Accreditation Handbook

The Accreditation Association for Ambulatory Health Care (AAAHC) is moving forward with enhanced Standards in version 41 of its Accreditation Handbook for Ambulatory Health Care. For more than 40 years, AAAHC has provided facilities with relevant standards and...


Stereotaxis, the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, announced today that HCA Midwest Health—the largest healthcare system in the Kansas City region—has launched a new robotic arrhythmia care program based at Overland Park Regional Medical Center (OPRMC). Installation of the Stereotaxis Robotic Magnetic Navigation (RMN) System was recently completed, and the first patients have been successfully treated using the technology at Overland Park Regional Medical Center.

Stereotaxis’ partnership with HCA Midwest Health brings new, leading-edge treatment options for patients who have a cardiac arrhythmia. The addition of RMN is a key component of the cardiology program at OPRMC and HCA Midwest Health, allowing for patient-focused clinical and technological leadership as well as enabling the providers and clinical team to better address a range of complex arrhythmias that otherwise might not have been treatable.

RMN uses robotics and magnetic fields to navigate a cardiac catheter directly from the tip. The technology consists of two robotically controlled magnets placed next to the operating table. During the procedure, a physician uses a computer interface to adjust the magnetic field around the patient and precisely direct and steer this cardiac ablation catheter in the heart.

Dr. Dhanunjaya “DJ” Lakkireddy, Medical Director, Kansas City Heart Rhythm Institute at HCA Midwest Health and a partner of Midwest Heart and Vascular Specialists, has been at the forefront of this technological innovation. Dr. Lakkireddy was instrumental in authoring the meta-analysis published in the Journal of Interventional Cardiac Electrophysiology (September 2017). The study emphasized the clinical value of robotics for the treatment of arrhythmias.

“The new cardiac arrhythmia labs at OPRMC were recently opened and are currently treating patients,” said Dr. Lakkireddy. “They represent the latest advances in the field of electrophysiology including robotic technology that enables improved outcomes and unparalleled safety for patients during cardiac ablation procedures. Robotics also allows OPRMC electrophysiologists to better address a range of complex arrhythmias that otherwise might not have been treated, providing hope to many patients who otherwise would have had no options for cardiac arrhythmia. We have observed the clinical value of robotic cardiac ablation and are excited to be providing patients convenient access to this technology.”

“As a world-renowned leader in electrophysiology research and patient care, Dr. Lakkireddy recognizes the significant patient, provider, and physician benefits of RMN. Stereotaxis technology affords OPRMC increased capabilities and a new and novel way to treat patients with cardiac arrhythmias,” explained David Fischel, Chairman and Chief Executive Officer of Stereotaxis. “We look forward to supporting the Kansas City Heart Rhythm Institute and HCA Midwest Health as they improve patient care, advance clinical science, and grow a highly successful robotic arrhythmia care practice in Kansas City.”



Submit a Comment

Your email address will not be published. Required fields are marked *